0ME:FRA
Twist Bioscience Corp
€144.85
arrow_downward
-1.60%(-2.35) 1D
Sep 22, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0ME...
Open
€141.15
High
€147.45
Low
€141.15
Mkt. cap
10.91B
Avg. vol.
59.00
Volume
138.00
52-wk high
€147.45
52-wk low
€21.69
Shares outstanding
222.04M
No. of employees
979
Open
€141.15
High
€147.45
Low
€141.15
Mkt. cap
10.91B
Avg. vol.
59.00
Volume
138.00
52-wk high
€147.45
52-wk low
€21.69
Shares outstanding
222.04M
No. of employees
979
News stories
From web sources and news partners
Yahoo Finance
·
18 hours ago
Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership
Investing.com UK
·
19 hours ago
Form 144 Twist Bioscience Corp For: 22 September By Investing.com
AD HOC NEWS
·
1 day ago
Twist Bioscience stock holds near 52-week high after CEO share sale
Stock Titan
·
1 day ago
After $1.8M stock sale, Twist Bioscience (NASDAQ: TWST) insider files to sell more
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp